NeuroSense Therapeutics Ltd. Share Premium
NeuroSense Therapeutics Ltd. (NRSN) had Share Premium of $30.19 million as of 2023-12-31, per its 20-F filed 2024-04-04.
Discontinued › Notes
ifrs-full:SharePremium · last filed 2024-04-04
- 2023-12-31: Share Premium $30.19M.
- 2023-06-30: Share Premium $28.36M.
- 2022-12-31: Share Premium $26.41M.
- 2022-06-30: Share Premium $24.48M.
| Period end | Share Premium |
|---|---|
| 2023-12-31 | $30.19M 20-F · filed 2024-04-04 |
| 2023-06-30 | $28.36M 6-K · filed 2023-08-16 |
| 2022-12-31 | $26.41M 20-F · filed 2024-04-04 |
| 2022-06-30 | $24.48M 6-K/A · filed 2023-01-19 |
| 2021-12-31 | $17.45M 20-F · filed 2023-03-22 |
| 2020-12-31 | $5.06M 20-F · filed 2022-04-14 |